Genetic and biochemical studies suggest that some forms of lens opacities or cataracts are associated with decreased chaperone-like activities of α-crystallins. The αA(−/−) knockout mice develop microphthalmia and small lenses with nuclear cataracts.
23 The nuclear cataract is associated with αB inclusion bodies and a significant amount of water insoluble γ-crystallin.
2 Unexpectedly, the αB(−/−) knockout mice develop clear lenses,
24 in addition, lens epithelial cells derived from αB-crystallin knockout mice undergo hyperproliferation
25 in culture. Mutations of either αA- or αB-crystallin cause dominant or recessive cataracts in humans and mice. The human αA-R49C, αA-R116C, and αA-R116H missense mutations and the mouse αA-V124E missense mutation are linked to dominant nuclear cataracts.
26 27 28 29 Human αA-W9X nonsense mutation and human αA-R54C point mutations, as well as mouse αA-R54H or R54C mutations, cause recessive cataracts.
30 31 32 33 A frame-shift mutation and a missense mutation αB-R120G cause dominant cataracts in humans.
34 The Arg
116 of αA-crystallin is the residue corresponding to the Arg
120 of αB-crystallin, and both αA-R116C and αB-R120G mutant proteins have decreased chaperone-like activities for some target proteins in vitro.
35 36 37 Transgenic mice that express human αA-R116C reveal unique pathologic events.
38 Recently, the human αB-D140N mutation has been shown to cause dominant cataracts by abolishing its chaperone-like activity and by acting as a dominant negative inhibitor to suppress the chaperone-like activity of wild-type αB-crystallin.
39 Thus, it is clear that a decreased chaperone-like activity of α-crystallin is detrimental to the lens transparency. However, it is unclear whether an increased chaperone-like activity of α-crystallin is beneficial for the lens transparency.